| 1630 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
H2AFX |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
phosphorylated histone 2A.X |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 1631 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
H2AFX |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
phosphorylated histone 2A.X |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 1632 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
H2AFX |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
phosphorylated histone 2A.X |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2228 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
CCL2 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Mus musculus |
monocyte chemoattractant protein 1 (MCP-1 |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2237 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
MPO |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
Myeloperoxidase (MPO) |
Protein |
10 |
10 |
Luminex-based immunoassays |
NM |
| 2238 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
MPO |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
Myeloperoxidase (MPO) |
Protein |
10 |
10 |
Luminex-based immunoassays |
NM |
| 2239 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL6 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
interleukin 6 |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2240 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
TNF |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
TNFα |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2241 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL10 |
DOWN |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
Interleukin 10 |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2244 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
NOS2 |
DOWN |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vivo |
Mus musculus |
inducible nitric oxide synthase (iNOS) |
Protein |
10 |
10 |
Luminex-based immunoassays |
NM |
| 2245 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
CCL2 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vivo |
Mus musculus |
monocyte chemoattractant protein 1 (MCP-1 |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2246 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL1B |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vivo |
Mus musculus |
interleukin 1 beta |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2247 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL1B |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vivo |
Mus musculus |
interleukin 1 beta |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2248 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
CSF2 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vivo |
Mus musculus |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2272 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
MPO |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Myeloperoxidase (MPO) |
Protein |
10 |
10 |
Luminex-based immunoassays |
NM |
| 2273 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
NOS2 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
inducible nitric oxide synthase (iNOS) |
Protein |
10 |
10 |
Luminex-based immunoassays |
NM |
| 2274 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
NOS2 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
inducible nitric oxide synthase (iNOS) |
Protein |
10 |
10 |
Luminex-based immunoassays |
NM |
| 2275 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
CCL2 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
monocyte chemoattractant protein 1 (MCP-1 |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2276 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL6 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Interleukin 6 |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2277 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL6 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
interleukin 6 |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2278 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL1B |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
interleukin 1 beta |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2279 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
TNF |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
TNFα |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2280 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
TNF |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
TNFα |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2281 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
CSF2 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2282 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
CSF2 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) |
Protein |
10 |
10 |
Western blot analysis |
NM |
| 2283 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL10 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Interleukin 10 |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 2284 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
IL10 |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Interleukin 10 |
Protein |
10 |
10 |
Flow cytometry |
NM |
| 3969 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
glutathione |
DOWN |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Mus musculus |
Glutathione (GSH) |
Metabolite |
10 |
10 |
Immunoturbidimetric assay |
NM |
| 3970 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
glutathione |
DOWN |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Mus musculus |
Glutathione (GSH) |
Metabolite |
10 |
10 |
Immunoturbidimetric assay |
NM |
| 3971 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
glutathione |
DOWN |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Mus musculus |
Glutathione (GSH) |
Metabolite |
10 |
10 |
Immunoturbidimetric assay |
NM |
| 4051 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
reactive oxygen species |
DOWN |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Mus musculus |
Reactive Oxygen Species |
Metabolite |
10 |
10 |
Western blot analysis |
NM |
| 4052 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
reactive oxygen species |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
Reactive Oxygen Species |
Metabolite |
10 |
10 |
Western blot analysis |
NM |
| 4053 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
reactive oxygen species |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
Reactive Oxygen Species |
Metabolite |
10 |
10 |
Western blot analysis |
NM |
| 5298 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
8-OHdG |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Mus musculus |
8-hydroxy-2-deoxyguanosine (8-OHdG) |
Phenotype |
10 |
10 |
Luminex-based immunoassays |
NM |
| 5299 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
8-OHdG |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.01 |
|
in vivo |
Mus musculus |
8-hydroxy-2-deoxyguanosine (8-OHdG) |
Phenotype |
10 |
10 |
Luminex-based immunoassays |
NM |
| 5300 |
Acute Sulfur Mustard Exposure |
Blood (serum) |
8-OHdG |
NC |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
NM |
|
in vivo |
Mus musculus |
8-hydroxy-2-deoxyguanosine (8-OHdG) |
Phenotype |
10 |
10 |
Luminex-based immunoassays |
NM |